Long-term safety and efficacy of MBA-P01 for the treatment of glabellar lines: results from a multicenter, repeated-dose, open-label extension study

被引:1
作者
Han, Hye Sung [1 ]
Kim, Won-Serk [2 ]
Lee, Yang Won [3 ]
Won, Chong Hyun [4 ]
Lee, Wooshun [5 ]
Choi, Sun Young [1 ]
Kim, Beom Joon [6 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Dermatol, Gwangmyeong Hosp, Anseong, Gyeonggi Do, South Korea
[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Dermatol, Seoul, South Korea
[3] Konkuk Univ, Sch Med, Dept Dermatol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea
[5] Medytox Inc, Seoul, South Korea
[6] Chung Ang Univ, Chung Ang Univ Hosp, Dept Dermatol, Coll Med, Seoul, South Korea
关键词
Glabellar lines; botulinum toxin; new botulinum toxin (MBA-P01); long-term safety; open-label extension study; TOXIN TYPE-A; BOTULINUM; PTOSIS; INJECTION;
D O I
10.1080/09546634.2024.2418919
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Clinical trial registration information: This study is registered in ClincalTrials.gov (NCT05321979).
引用
收藏
页数:8
相关论文
共 32 条
[21]   Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized, open-label trial [J].
Jiang, Hui ;
Zhao, Lian-Ming ;
Lin, Hao-Cheng ;
Yan, Su ;
Liu, Ji-Hong ;
Zhu, Zhao-Hui ;
Luo, Jin-Dan ;
Dai, Yu-Tian ;
Li, Fu-Biao ;
Lou, Ying ;
Zhang, Zhi-Chao .
ASIAN JOURNAL OF ANDROLOGY, 2018, 20 (06) :587-592
[22]   Rationale and design of the VISION study: a randomized, open-label study to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive esophagitis [J].
Uemura, Naomi ;
Kinoshita, Yoshikazu ;
Haruma, Ken ;
Yao, Takashi ;
Kushima, Ryoji ;
Kanoo, Tatsuhiro .
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2018, 11 :51-56
[23]   Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial [J].
Klein, Brad C. ;
Miceli, Rosa ;
Severt, Lawrence ;
McAllister, Peter ;
Mechtler, Laszlo ;
McVige, Jennifer ;
Diamond, Merle ;
Marmura, Michael J. ;
Guo, Hua ;
Finnegan, Michelle ;
Trugman, Joel M. .
CEPHALALGIA, 2023, 43 (01)
[24]   Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial [J].
Toledo, Manuel ;
Brandt, Christian ;
Quarato, Pier Paolo ;
Schulz, Anne-Liv ;
Cleveland, Jody M. ;
Wagener, Gilbert ;
Klein, Pavel .
EPILEPSY & BEHAVIOR, 2021, 118
[25]   Efficacy and Safety of a Newly Developed Botulinum Toxin A (MBA-P01) in Patients with Moderate-to-Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled, Multi-Center, Phase III Study with a Subgroup Analysis on Patients with COVID-19 [J].
Han, Hye Sung ;
Kim, Won-Serk ;
Lee, Yangwon ;
Won, Chong-Hyun ;
Lee, Wooshun ;
Choi, Sun Young ;
Kim, Beom Joon .
TOXINS, 2025, 17 (04)
[26]   Long-Term Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder An Open-Label, Dose-Titration, 1-Year Study [J].
Adler, Lenard A. ;
Orman, Camille ;
Starr, H. Lynn ;
Silber, Steve ;
Palumbo, Joseph ;
Cooper, Kimberly ;
Berwaerts, Joris ;
Harrison, Diane D. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (01) :108-114
[27]   A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine [J].
Munjal, Sagar ;
Brand-Schieber, Elimor ;
Allenby, Kent ;
Spierings, Egilius L. H. ;
Cady, Roger K. ;
Rapoport, Alan M. .
JOURNAL OF HEADACHE AND PAIN, 2017, 18
[28]   A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine [J].
Sagar Munjal ;
Elimor Brand-Schieber ;
Kent Allenby ;
Egilius L.H. Spierings ;
Roger K. Cady ;
Alan M. Rapoport .
The Journal of Headache and Pain, 2017, 18
[29]   Efficacy and Safety of OnabotulinumtoxinA Therapy are Sustained Over 4 Years of Treatment in Patients With Neurogenic Detrusor Overactivity: Final Results of a Long-Term Extension Study [J].
Kennelly, Michael ;
Dmochowski, Roger ;
Schulte-Baukloh, Heinrich ;
Ethans, Karen ;
Del Popolo, Giulio ;
Moore, Courtenay ;
Jenkins, Brenda ;
Guard, Steven ;
Zheng, Yan ;
Karsenty, Gilles .
NEUROUROLOGY AND URODYNAMICS, 2017, 36 (02) :368-375
[30]   Safety and Efficacy of Diluted Calcium Hydroxylapatite for the Treatment of Cellulite Dimpling on the Buttocks: Results from an Open-Label, Investigator-Initiated, Single-Center, Prospective Clinical Study [J].
Durairaj, Kay ;
Baker, Omer ;
Yambao, Monalea ;
Linnemann-Heath, Jacob ;
Shirinyan, Ani .
AESTHETIC PLASTIC SURGERY, 2024, 48 (09) :1797-1806